Fax: (713) 794-4385.
Original Article
You have full text access to this OnlineOpen article
Multifocal breast cancer in women ≤35 years old†
Article first published online: 3 AUG 2007
DOI: 10.1002/cncr.22928
Copyright © 2007 American Cancer Society
Additional Information
How to Cite
Litton, J. K., Eralp, Y., Gonzalez-Angulo, A. M., Broglio, K., Uyei, A., Hortobagyi, G. N. and Arun, B. (2007), Multifocal breast cancer in women ≤35 years old. Cancer, 110: 1445–1450. doi: 10.1002/cncr.22928
- †
Presented in part as a poster at the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, Georgia, June, 2006.
- ‡
Fax: (713) 794-4385.
Publication History
- Issue published online: 14 SEP 2007
- Article first published online: 3 AUG 2007
- Manuscript Accepted: 22 MAY 2007
- Manuscript Revised: 15 MAY 2007
- Manuscript Received: 7 FEB 2007
Funded by
- Breast Cancer Research Fund
REFERENCES
- 1, , , et al. SEER Cancer Statistics Review 1975–2003. Bethesda, MD: National Cancer Institute; 2005.
- 2, , , et al. Women age < 35 years with primary breast carcinoma. Cancer. 2005; 103: 2466–2472.
- 3
- 4, , , et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis. Cancer. 2001; 92: 2523–2528.
- 5, , , et al. The Eurocare Working Group, survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. Int J Cancer. 1998; 77: 679–683.
- 6, , , . Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996; 77: 97–103.
- 7, , , et al. Modeling the effect of age in T1-2 breast cancer using the SEER database. BMC Cancer. 2005; 5: 130.
- 8, , . Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat. 2007; 101: 51–57.
- 9, . Young age and outcome for women with early stage invasive breast carcinoma. Cancer. 2004; 101: 1264–1274.
- 10, , , , . The relation between survival and age at diagnosis in breast cancer. N Engl J Med. 1986; 315: 559–63.
- 11, , , et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol. 1994; 12: 888–894.
- 12, , . The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer. 1996; 78: 1838–1843.
- 13, , . Prognostic significance of young age in breast cancer. J Surg Oncol. 2000; 74: 267–272.
- 14, , , , , . Do young breast cancer patients have worse outcomes? J Surg Res. 2003; 113: 109–113.
- 15, , , , . Breast cancer in young women: clinicopathological features and biological specificity. Breast 2003; 12: 247–250.
- 16, , , . Breast carcinomas occurring in young women (< 35 years) are different. Br J Cancer. 1996; 74: 1796–1800.
- 17
- 18
- 19, , , . Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast conserving surgery. Cancer 1985; 56: 979–990.
- 20, , , , , . Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol. 2005; 60: 573–578.
- 21, , , et al. Breast conservation after neoadjuvant chemotherapy. Cancer 2005; 103: 689–695.
- 22, , , . Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg. 2001; 71: 723–728.
- 23. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer. 1982; 49: 1123–1130.
- 24, , , , , . Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002; 94: 1383–1390.
- 25, . Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol. 2005; 23: 7497–7502.
- 26, , , . Correlation of tumor volume and surface area with lymoh node status in patients with multifocal/multicentric breast carcinoma. Cancer. 2004; 100: 20–27.
- 27American Joint Commission on Cancer: Breast AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven; 1997: 127–133.
- 28, , , et al. Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg. 1995; 222: 612–618.
- 29, , , , , . Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol. 2001; 19: 4224–4237.
- 30The World Health Organization histological typing of breast tumors, 2nd ed. Am J Clin Pathol. 1982;78: 806–816.
- 31, . Nuclear structure in cancer tissue. Surg Gynecol Obstet. 1982; 105: 97–102.
- 32, , , et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001; 344: 783–792.
- 33, , , et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst. 1995; 87: 827–835.
- 34, , , . Breast cancer among young US women in relation to oral contraceptive use. J Natl Cancer Inst. 1994; 86: 505–514.
- 35, , , et al. Unopposed estrogen therapy and the risk of invasive cancer. Arch Intern Med. 2006; 166: 1027–1032.
- 36, , , et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Clin Oncol. 2000; 18: 296.
- 37, , , . Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age. Cancer 2000; 88: 2553–2560.
- 38, , , et al. Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: the University of Texas M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys. 2002; 54: 804–809.

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)